secwatch.observer — SEC 8-K summary
======================================

Issuer:     Phio Pharmaceuticals Corp. (PHIO)
CIK:        0001533040
Form:       8-K
Filed at:   2025-04-22T23:59:59+00:00
Accession:  0001683168-25-002725
Event type: other_material
Sentiment:  neutral
Materiality: 0.40
Item codes: 4.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Phio Pharmaceuticals dismisses BDO and engages Grant Thornton as auditor
------------------------------------------------------------------------

- Audit Committee dismissed BDO USA as independent auditor effective April 17, 2025.
- Grant Thornton LLP appointed as new independent auditor for fiscal year ending Dec 31, 2025.
- No disagreements or reportable events occurred during BDO's tenure through April 17, 2025.
- BDO's reports for FY2024 and FY2023 included going-concern explanatory paragraphs.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1533040/000168316825002725/0001683168-25-002725-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1533040/000168316825002725/phio_8k.htm
  HTML page:      https://secwatch.observer/filing/0001683168-25-002725

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer